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Enhancing Structural Support of the Dermal
Microenvironment Activates Fibroblasts, Endothelial
Cells, and Keratinocytes in Aged Human Skin In Vivo
Taihao Quan1,2, Frank Wang1,2, Yuan Shao1, Laure Rittie´1, Wei Xia1, Jeffrey S. Orringer1, John J. Voorhees1 and
Gary J. Fisher1
The dermal extracellular matrix (ECM) provides strength and resiliency to skin. The ECM consists mostly of type I
collagen fibrils, which are produced by fibroblasts. Binding of fibroblasts to collagen fibrils generates mechanical
forces, which regulate cellular morphology and function. With aging, collagen fragmentation reduces fibroblast–
ECM binding and mechanical forces, resulting in fibroblast shrinkage and reduced function, including collagen
production. Here, we report that these age-related alterations are largely reversed by enhancing the structural
support of the ECM. Injection of dermal filler, cross-linked hyaluronic acid, into the skin of individuals over
70 years of age stimulates fibroblasts to produce type I collagen. This stimulation is associated with localized
increase in mechanical forces, indicated by fibroblast elongation/spreading, and mediated by upregulation of
type II TGF-b receptor and connective tissue growth factor. Interestingly, enhanced mechanical support of the
ECM also stimulates fibroblast proliferation, expands vasculature, and increases epidermal thickness. Consistent
with our observations in human skin, injection of filler into dermal equivalent cultures causes elongation of
fibroblasts, coupled with type I collagen synthesis, which is dependent on the TGF-b signaling pathway. Thus,
fibroblasts in aged human skin retain their capacity for functional activation, which is restored by enhancing
structural support of the ECM.
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INTRODUCTION
The dermal extracellular matrix (ECM) has vital roles in
structural support, immunity, circulation, and sensory percep-
tion (Uitto and Bernstein, 1998; Fisher et al., 2008; Quan
et al., 2009). Dermal ECM supports the epidermis and consists
mostly of type I collagen fibrils, which are synthesized by
fibroblasts. As the most abundant structural protein in the
dermis, type I collagen provides strength and resiliency to skin
(Fisher et al., 2008).
A wealth of evidence indicates that interactions between
adherent cells, such as fibroblasts, and the ECM are critical
for cellular function (Lambert et al., 1992; Ingber, 1997;
Ruoslahti, 1997; Kessler et al., 2001; Grinnell, 2003; Silver
et al., 2003; Eckes et al., 2006; Fisher et al., 2008; Dupont
et al., 2011). In healthy young skin, dermal fibroblasts attach
to collagen fibrils through transmembrane integrin receptors.
Engagement of integrins with the ECM triggers the formation of
focal adhesion complexes, which couple the ECM to the
intracellular actin cytoskeleton (Lambert et al., 1998; Eckes
et al., 2006; Delon and Brown, 2007; Olson and Nordheim,
2010). The actin cytoskeletal machinery generates mechanical
forces that determine cell shape, which in turn greatly influences
fibroblast function (Grinnell, 2003; Silver et al., 2003; Ingber,
2006; Fisher et al., 2008; Olson and Nordheim, 2010).
With aging, dermal collagen fibrils undergo enzyme-cata-
lyzed cleavage (Fisher et al., 2002; Fligiel et al., 2003; Fisher
et al., 2008). This degenerative process compromises the
mechanical microenvironment of the dermis and impairs
fibroblast attachment to the ECM, resulting in reduced mech-
anical forces (Varani et al., 2006). Consequently, fibroblasts in
aged skin display a collapsed cytoplasm and rounded shape,
which contrasts with the spread shape of fibroblasts in young
skin. Importantly, fibroblasts with a collapsed morphology
downregulate the production of type I collagen and upregulate
the production of collagen-degrading matrix metallopro-
teinases (MMPs; Varani et al., 2001; Fligiel et al., 2003;
Varani et al., 2006; Fisher et al., 2008).
The TGF-b signaling pathway is influenced by mechanical
force and is pivotal to dermal fibroblast function (Varga and
Jimenez, 1995; Rittie and Fisher, 2002; Eckes et al., 2006;
Fisher et al., 2009). TGF-b is a multifunctional cytokine that
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acts through a receptor complex composed of type I, II, and III
TGF-b receptors (TbRs; Massague and Gomis, 2006). TGF-b
induces connective tissue growth factor (CTGF/CCN2), which
in concert with TGF-b regulates fibroblast function, including
synthesis of type I procollagen and other ECM proteins
(Duncan et al., 1999; Rittie and Fisher, 2002; Quan et al.,
2002a; Oliver et al., 2010; Quan et al., 2010). In fibroblasts in
aged skin, reduced TGF-b-mediated signaling and CTGF/
CCN2 expression contribute to decreased collagen produc-
tion (Quan et al., 2006, 2010).
Clinically, impaired fibroblast function, coupled with
reduced collagen synthesis, translates into atrophy, wrinkling,
and fragility of aged skin (Lapiere, 1990; Fisher et al., 2008).
We hypothesized that fibroblast function in naturally aged skin
could be stimulated by enhancing the structural support of the
ECM with an injectable space-filling material, cross-linked
hyaluronic acid (HA; Wang et al., 2007). HA, which is a com-
ponent of the ECM in all tissues, is a glycosaminoglycan
disaccharide composed of repeating units of D-glucuronic acid
and N-acetyl-D-glucosamine. HA-based dermal fillers are
composed of disaccharide chains ranging in molecular
weight from 500,000 to 6,000,000 that are cross-linked with
butanediol diglycidyl ether (Kablik et al., 2009). We report
that injection of this filler induces fibroblast spreading, in turn
stimulating type I collagen production. Our data, therefore,
indicate that fibroblasts in aged skin retain their capacity for
functional activation, highlighting the importance of the ECM
microenvironment in regulating fibroblast behavior. Thus,
aging of connective tissue in skin, and perhaps in other
organs, is largely attributable to alterations in the extracel-
lular microenvironment, in addition to inherent cellular
changes.
RESULTS
Expression of type I procollagen in aged human skin is restored
by enhancing the structural support of the dermal ECM
We injected vehicle (saline) or filler into buttock skin of
aged individuals (81.4±1.0 years old) and obtained biopsies
after 1, 2, 4, and 12 weeks. We initially evaluated whether
injection caused an inflammatory response. Neither clinical
nor histological inflammation (determined by immunostaining
for immune/inflammatory monocytes, macrophages, and neu-
trophils) was observed in any subject during the course of the
study (data not shown). This lack of inflammation following
injection of cross-linked HA has been reported previously
(Flynn et al., 2011). As reduced fibroblast function and ECM
synthesis are prominent features of aged skin, we first analyzed
the localization of type I procollagen protein expression by
immunohistochemistry. Type I procollagen is the precursor
of mature type I collagen fibrils. Compared with vehicle
injection, filler injection induced intense immunostaining
within the ECM and dermal fibroblasts (Figure 1a). Staining
was particularly strong adjacent to pockets of injected filler,
which were present primarily in the mid-to-lower dermis.
Interestingly, positively stained fibroblasts tended to align
around pockets of injected filler and exhibited an enlarged,
elongated morphology, indicating increased mechanical force
and structural support within the dermal ECM (Figure 1a,
inset). Elongated fibroblasts were mostly embedded within
ECM fibers surrounding pockets of injected filler but not
directly contacting the filler material. Overall, the amount of
staining was increased 6-fold at 4 weeks post filler injection
and remained elevated for at least 12 weeks (Figure 1a).
Quantitation by ELISA confirmed type I procollagen protein
induction (Figure 1b).
In addition, we performed immunostaining for two proteins
induced in fibroblasts actively producing type I procollagen.
Prolyl-4-hydroxylase catalyzes the formation of hydroxypro-
line, which is required for stable assembly of the triple helical
region of type I collagen, and heat shock protein 47 (HSP47) is
an intracellular molecular chaperone required for shuttling
type I procollagen through the endoplasmic reticulum during
synthesis. Staining patterns for prolyl-4-hydroxylase (Figure 1c)
and HSP47 (Figure 1d) were similar to that of type I procolla-
gen, with elongated/spread fibroblasts surrounding filler
displaying increased and intense staining at 4 and 12 weeks,
compared with vehicle-treated skin (Figure 1c and d).
To complement our immunostaining results, we measured
gene expression of type I procollagen, prolyl-4-hydroxylase,
HSP47, and type III procollagen, the precursor of type III
collagen, which associates with type I collagen fibrils. The
expression of these genes was significantly induced at 4 weeks
post filler injection, and, with the exception of HSP47,
their expression remained elevated for at least 12 weeks
(Supplementary Figure S1 online). These data indicate that
enhanced structural support of the dermal ECM induces
fibroblast elongation and procollagen synthesis in aged
human skin.
Enhanced structural support of the dermal ECM upregulates
type I procollagen expression and the TGF-b pathway
specifically in elongated fibroblasts in aged human skin
As procollagen-producing fibroblasts appeared elongated and
aligned around pockets of deposited filler (Figure 2a), we next
used laser capture microdissection to specifically isolate these
cells and analyze their gene expression. Consistent with
our immunostaining results, elongated fibroblasts surrounding
injected filler demonstrated a 12-fold induction of type I
procollagen gene expression, compared with an equivalent
number of fibroblasts from the middle and deep dermis of
vehicle-injected skin (Figure 2b).
In addition, we measured TbRII and CTGF/CCN2 gene expres-
sion in laser capture microdissection-captured fibroblasts.
Elongated fibroblasts adjacent to filler exhibited a 3-fold and
10-fold induction of TbRII and CTGF/CCN2, respectively, com-
pared with cells from vehicle-injected skin (Figure 2b). These
data indicate that enhanced structural support of the dermal ECM
upregulates the TGF-b pathway through induction of TbRII
and CTGF/CCN2 in elongated fibroblasts in aged human skin.
Deposition of mature collagen is increased by enhancing
structural support of the dermal ECM in aged human skin
Having found that enhanced mechanical support of the ECM
promotes type I procollagen synthesis, we next considered
whether newly produced procollagen is processed to form
stable collagen fibrils. To address this question, we used
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atomic force microscopy to assess the nanoscale structure of
collagen fibrils. In vehicle-injected skin, collagen fibrils in the
mid and deep dermis appeared disorganized and fragmented
(Figure 2c, left panel). However, in areas adjacent to injected
filler, we observed highly organized, dense bundles of
collagen fibrils, with a characteristic banded structure (D-
spacing) representing the staggered alignment of individual
collagen molecules within fibrils (Figure 2c, right panel).
These highly organized bundles extended from pockets of
injected filler as far away as B500mm. More distantly,
collagen fibrils appeared similar to those in vehicle-injected
skin (Supplementary Figure S2 online). In addition, we
performed a metabolic labeling assay to measure the rate of
production of insoluble collagen fibrils. Skin samples obtained
4 weeks after vehicle or filler injection were incubated with
[14C]-proline, and insoluble collagen was extracted after
48 hours. The level of radioactivity was 90% greater in filler-
versus vehicle-injected skin (Po0.05, data not shown). These
findings indicate that enhanced structural support of the
dermal ECM stimulates synthesis of procollagen, which is
processed into mature collagen in aged human skin.
Enhanced structural support of the dermal ECM is associated
with increased epidermal proliferation and thickening in aged
human skin
Aged human skin is characterized by a thin epidermis, caused
in part by decreased proliferation of basal keratinocytes
(Zouboulis and Makrantonaki, 2011). Interestingly, we
noticed that epidermal thickness appeared greater following
injection of filler, compared with vehicle. Indeed, quantitative
morphometric analyses revealed that epidermal thickness was
increased by 19% and 14% at 4 and 12 weeks, respectively,
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Figure 1. Type I procollagen expression in aged human skin is restored by enhancing structural support of the dermal microenvironment. Aged human skin was
biopsied 4 and 12 weeks after injection of vehicle or filler. (a) Immunostaining of type I procollagen protein at 4 weeks (left panels) and 12 weeks (right panels;
n¼ 21). Insets display elongated morphology of immunostained fibroblasts adjacent to pools of filler (w). Graphs display staining quantification. (b) The level of
type I procollagen protein was determined by ELISA (n¼22). Immunostaining localization of (c) prolyl-4-hydroxylase (n¼ 22) and (d) heat shock protein 47
(HSP47, n¼10) to fibroblasts adjacent to pools of filler (w) at 4 weeks (left panels) and 12 weeks (right panels), with quantification of staining. All images,
bars¼ 100mm; meansþ SEM. *Po0.05.
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after filler injection (Figure 3a). In addition, keratinocyte
proliferation, assessed by Ki67 immunostaining, was signifi-
cantly increased within 1–2 weeks after filler injection
(Figure 3b). Thus, enhanced structural support of the dermal
ECM is associated with increased keratinocyte proliferation
and epidermal thickening.
Enhanced structural support of the dermal ECM is associated
with proliferation of endothelial cells and fibroblasts in aged
human skin
In addition to epidermal changes, we noticed increased
prominence of blood vessels in the mid-to-deep dermis in
filler-injected skin. Indeed, immunostaining for the endothelial
cell marker CD31 revealed increased staining by 60% and
97% at 4 and 12 weeks, respectively, after filler injection,
compared with vehicle injection (Figure 4a).
Next, having observed increased proliferation of epidermal
cells and increased prominence of endothelial cells, we
examined proliferation of dermal cells. As early as 1–2 weeks
after filler injection, dermal cell proliferation, assessed by Ki67
immunostaining, was readily evident in filler-injected skin,
particularly in areas adjacent to the filler material (Figure 4b).
Dermal cell proliferation was rarely detected in vehicle-
injected skin.
Positively stained cells in filler-injected skin appeared to
include a fraction of endothelial cells and fibroblasts. There-
fore, we performed double-label immunofluorescence staining
to confirm the identity of proliferating cells. We found Ki67/
CD31-positive endothelial cells in vessel structures near
pockets of the injected filler (Figure 4c, upper row). Similarly,
Ki67/HSP47-positive fibroblasts were localized to areas adja-
cent to the injected filler (Figure 4c, bottom row). Together,
these data indicate that enhanced structural support of the
dermal ECM is associated with proliferation of endothelial
cells and fibroblasts in aged human skin.
Enhanced structural support in three-dimensional collagen
lattices induces fibroblast elongation and upregulates collagen
production via the TGF-b signaling pathway
To further elucidate the mechanisms by which enhanced
structural support stimulates fibroblasts, we used dermal equi-
valent cultures composed of human dermal fibroblasts embedded
in three-dimensional collagen lattices. After focal injection
into collagen lattices, filler material remained confined to pockets
at injection sites, where it caused localized expansion of
lattices (Figure 5a). Thus, the space-filling property of injected
filler in collagen lattices appeared similar to that observed in
human skin. Injection of vehicle had no observable effect on
lattices.
Consistent with our findings in human skin, we observed
intense immunostaining of type I procollagen within elongated
fibroblasts adjacent to pockets of injected filler (Figure 5a). In
addition, protein levels of secreted type I procollagen were
increased B2-fold in filler-injected cultures, compared with
vehicle injection (Figure 5b). Filler injection also increased
the gene expression of HSP47 and prolyl-4-hydroxylase
(Supplementary Figure S3 online).
As mentioned previously, expression of type I procollagen is
dependent on the TGF-b/CCN2 axis (Quan et al., 2006, 2010).
Similar to our data on human skin, we found that type I
procollagen, TbRII, and CTGF/CCN2 gene expression was
significantly induced following filler injection into dermal
equivalent cultures (Figure 5c). As noted above, expansion
of collagen lattices occurs after filler injection. To examine the
role of this expansion, non-cross-linked HA, which readily
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Figure 2. Enhanced structural support upregulates the transforming growth
factor (TGF)-b pathway and collagen deposition in aged human skin
fibroblasts. Skin was obtained 4 weeks after injection of vehicle or filler.
(a) Image of pools of injected filler (w), with adjacent elongated fibroblasts
immunostained for type I procollagen (bar¼ 50mm). (b) Fibroblasts from
vehicle- and filler-injected skin were isolated by laser capture microdissection
and analyzed for type I procollagen (COL-1, n¼9), type II TGF-b receptor
(TbRII, n¼ 9), and connective tissue growth factor (CCN2, n¼ 7) gene
expression. Meansþ SEM, *Po0.05. (c) Nanoscale structure of collagen fibrils
imaged by atomic force microscopy (n¼ 3). Upper panels display probe
location in the mid dermis. Dotted lines around stars indicate filler pockets.
Collagen fibrils with a characteristic banded pattern appear intact, tightly
packed, and spatially organized in filler-injected skin but fragmented and
disorganized in vehicle-injected skin.
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diffuses within the lattices and does not cause expansion, was
injected. Similar to vehicle injection, injection of non-cross-
linked HA had no effect on type I procollagen, TbRII, and
CTGF/CCN2 gene expression (Figure 5c).
To further examine the role of lattice expansion in inducing
procollagen production, filler material was dispersed into
collagen solution before lattice formation. Under these con-
ditions, fibroblast morphology appeared similar to that in
untreated lattices or in lattices injected with vehicle or non-
cross-linked HA (data not shown). Furthermore, dispersal of
filler, as opposed to injection into preformed lattices, failed to
induce type I procollagen, TbRII, or CTGF/CCN2 (Figure 5d).
Thus, lattice deformation was required for the upregulation of
fibroblast function.
Finally, we investigated the role of the TGF-b pathway in
procollagen induction following filler injection. Addition of
TbRI kinase inhibitor to collagen lattices before filler injection
prevented the upregulation of type I procollagen and CTGF/
CCN2 (Figure 5e), indicating that collagen upregulation
following filler injection is dependent on the TGF-b signaling
pathway.
DISCUSSION
We have proposed that accumulation of fragmented collagen
during natural skin aging negatively affects fibroblast function
(Varani et al., 2001; Fisher et al., 2002; Varani et al., 2004,
2006; Fisher et al., 2008). Collagen fragmentation alters the
physical properties of the dermal microenvironment and
reduces ECM binding by fibroblasts, which in turn lessens
mechanical force. Under these conditions, fibroblasts down-
regulate collagen production and upregulate MMPs (Varani
et al., 2006; Fisher et al., 2008, 2009). This cellular response
promotes further loss and fragmentation of collagen, thereby
promoting self-perpetuating progression of the aged pheno-
type in human skin. Inherent to our model is the concept that
quality of the ECM, rather than chronological age of dermal
fibroblasts, is a key determinant of age-dependent decline in
fibroblast function.
In this study, we used a space-filling material, cross-linked
HA, as a tool to test the hypothesis that enhanced structural
support could stimulate fibroblast function in aged skin. We
observed that the filler, when injected focally into the skin,
distributes in the dermis as large pools, filling space and
pushing against the surrounding ECM. Adjacent to these
pockets of filler, fibroblasts display an elongated morphology,
indicating increased mechanical force and structural support
within the dermal ECM. Importantly, fibroblast elongation is
associated with upregulation of the TGF-b signaling pathway
and its downstream targets CTGF/CCN2 and type I procolla-
gen. Thus, we found that structural properties of the dermal
ECM have a significant role in modulating fibroblast function
during human skin aging. Furthermore, we conclude that
impaired fibroblast function in aged human skin is not solely
attributable to irreversible cellular alterations but instead is
dynamically responsive and, in part, reversible via manipula-
tion of the ECM microenvironment (Varani et al., 2002).
We considered the possibility that fibroblast stimulation
may occur by direct binding of filler to cellular receptors.
Addition of exogenous, monomeric HA to cultured fibroblasts
has been reported to trigger TGF-b signaling and collagen
production (Mast et al., 1993; David-Raoudi et al., 2008).
Some of these responses are mediated by binding of HA to
CD44, a cell surface glycoprotein (David-Raoudi et al., 2008).
However, other studies have not reproduced these obser-
vations (Croce et al., 2001; Huang et al., 2009). Here, we
observed that collagen-producing, elongated fibroblasts were
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Figure 3. Increased epidermal thickening and keratinocyte proliferation are associated with enhanced structural support of the dermal microenvironment
in aged human skin. Aged human skin was injected with vehicle or filler. Skin samples were obtained between 1 and 12 weeks later. (a) The epidermal thickness
of skin samples was measured by computerized image analysis (n¼ 21, bars¼ 100mm). (b) Immunostaining of the proliferation marker Ki67, with positive
cell staining in the epidermis quantified by image analysis (n¼ 6, bars¼100mm), and representative images at 1 week post injection. Bar graphs display
meansþ SEM. *Po0.05.
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embedded within the ECM adjacent to injected filler and did
not appear to directly contact the filler. Moreover, uniform
dispersion of filler or injection of non-CL-HA in dermal
equivalent cultures, unlike focal injection, failed to induce
fibroblast elongation or procollagen synthesis. These data
make it unlikely that injected filler acts through direct
interactions with fibroblast receptors.
Our findings, in fact, suggest that collagen production
following filler injection occurs by enhanced structural sup-
port within the dermal ECM. Supporting this interpretation is a
wealth of evidence, derived from model systems, indicating
that morphology and function of adherent cells are linked by
mechanical properties of the ECM (Lambert et al., 1992;
Ingber, 1997; Ruoslahti, 1997; Kessler et al., 2001; Varani
et al., 2002; Grinnell, 2003; Silver et al., 2003; Eckes et al.,
2006; Varani et al., 2006; Fisher et al., 2008; Dupont et al.,
2011). For instance, when cultured with fragmented collagen
fibrils, fibroblasts display a collapsed appearance, indicative of
low mechanical force. These cells lack direct attachment to
the ECM and adopt a catabolic phenotype, with decreased
collagen synthesis and upregulation of MMP-1 (Kessler et al.,
2001; Varani et al., 2002, 2004; Eckes et al., 2006; Varani
et al., 2006). This situation reflects aged human skin
(Fligiel et al., 2003; Fisher et al., 2008, 2009). In contrast,
immobilized three-dimensional matrices composed of intact
collagen fibrils provide a stable framework for fibroblast
adherence via integrins (Barczyk et al., 2010). In this setting,
fibroblasts display an elongated/spread morphology, coupled
with procollagen synthesis. This scenario reflects healthy
young human skin (Fligiel et al., 2003; Silver et al., 2003;
Varani et al., 2006; Fisher et al., 2008; Quan et al., 2010).
Interestingly, fibroblasts cultured in mechanically stiff ECM
also upregulate the production of TGF-b and its effector CTGF/
CCN2 (Kessler et al., 2001; Skutek et al., 2001; Garrett et al.,
2004; Eckes et al., 2006). TGF-b-mediated signaling, in turn,
modulates fibroblast responses to mechanical force by
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Figure 4. Proliferation of endothelial cells and fibroblasts is associated with enhanced structural support of the dermal microenvironment in aged human skin.
Aged human skin was injected with vehicle or filler and biopsied between 1 and 12 weeks later. Immunostaining of (a) endothelial cell marker CD31 (n¼10,
bar¼ 100mm) and (b) Ki67 (n¼6, bar¼100mm) near pockets of the injected filler (w), with quantification of staining. (c) Double-label immunofluorescence
staining of the dermis near the injected filler, with Ki67 (red) plus CD31 (green, top panels) or heat shock protein 47 (HSP47) (green, bottom panels) (n¼6).
Nuclei are stained with 4’,6-diamidino-2-phenylindole (DAPI) (blue). Dashed lines separate dermal extracellular matrix (ECM) from pools containing
injected filler (w). All representative images are from 2 weeks post filler injection. Bar graphs, meansþ SEM. *Po0.05.
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stimulating integrin expression and reorganization of the actin
cytoskeleton, suggesting that TGF-b is a ‘‘mechanoregulatory’’
growth factor (Brown et al., 2002; Grinnell and Ho, 2002).
In addition, the expression of TbRII is reduced in dermal
fibroblasts in aged human skin, thus decreasing cellular
responsiveness to TGF-b (Quan et al., 2006).
Given these observations, we propose that filler injection
into aged skin stiffens the ECM, which induces fibroblast
elongation and activation. The result is upregulation of
the TGF-b pathway leading to synthesis and deposition
of collagen. As mature collagen has an estimated half-life of
15 years (Verzijl et al., 2000), it is likely that newly formed
collagen fibrils facilitate additional elongation/spreading of
fibroblasts and, hence, further activation of TGF-b signaling.
We found that filler injection stimulates localized prolifera-
tion of fibroblasts, many of which are synthetically active.
Fibroblast proliferation can be driven by numerous mechan-
isms, including increased mechanical force (Varani et al.,
2002; Eckes et al., 2006). It has been reported that substrate
stiffness controls proliferation in a variety of cell types through
integrin-dependent signaling to FAK, Rac, and cyclin D1
(Klein et al., 2009). Similar mechanisms may be operative in
human skin in response to enhanced structural support by
injection of cross-linked HA. Increased fibroblast number
would be expected to contribute to collagen production
following filler injection.
Along with decreased fibroblast function and proliferation,
reduced vasculature and epidermal thinning contribute to fra-
gility and impaired wound healing in aged skin (Holt et al.,
1992; Chung and Eun, 2007; Zouboulis and Makrantonaki,
2011). Here, we observed that enhanced structural support of
the dermal ECM is associated with proliferation of endothelial
cells and keratinocytes. On the basis of previous studies,
proliferation of these cell types might result from increased
mechanical force (Chen et al., 1997; Reichelt, 2007) or from
production of diffusible mediators, such as VEGF, TGF-b, CTGF/
CCN2, and/or cysteine-rich angiogenic inducer 61 (Chen et al.,
2001; Kessler et al., 2001; Chen and Du, 2007; Shirakata,
2010). Additional studies may clarify which of these mechan-
isms are involved in stimulating endothelial and keratinocyte
proliferation following enhancement of structural support.
Together, our findings extend current knowledge of
mechanisms of skin aging beyond intrinsic cellular processes
to include the dermal ECM microenvironment. Our data
indicate that collagen production in aged skin can be
substantially restored. Restoration of this synthetic capacity is
intimately linked with structural integrity/support of the dermal
ECM, which dynamically interacts with fibroblasts and mod-
ulates their function and proliferation. Our data also indicate
that proliferation and function of other cell types, including
endothelial cells and keratinocytes, can be enhanced in aged
skin. These findings provide a rationale for maintaining and/or
enhancing the structural integrity of dermal ECM, which in
turn may improve the health, function, and wound healing
capacity of aged human skin.
MATERIALS AND METHODS
Procurement of skin specimens
This study was approved by our Institutional Review Board and was
conducted according to the Declaration of Helsinki principles.
Healthy volunteers (74–95 years old, 18 women, 10 men) provided
written informed consent and were administered two injections of
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Figure 5. Enhanced structural support of dermal equivalent cultures induces fibroblast elongation and upregulates the transforming growth factor (TGF)-b
pathway and collagen production. Dermal equivalent cultures were analyzed 2 days after treatment. (a) Immunostaining of type I procollagen within elongated
fibroblasts adjacent to pools of injected filler (w, purple; n¼ 3, bar¼ 100mm). (b) Type I procollagen protein secreted into culture media was quantified by ELISA
(n¼ 3). Type I procollagen (COL-1), CCN2, and type II TGF-b receptor (TbRII) gene expression following (c) vehicle, non-cross-linked hyaluronic acid (CL-HA), or
filler injection into preformed lattices (n¼ 4, *Pp0.05 vs. vehicle), (d) vehicle or filler dispersed in collagen solution before lattice formation (n¼4), and (e) addition of
type I TGF-b receptor (TbRI) kinase inhibitor before injection of vehicle or filler (n¼ 4, *Po0.05 vs. filler injection without inhibitor). IHC, immunohistochemistry.
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filler (Restylane, cross-linked HA, Medicis, Scottsdale, AZ) and two
injections of vehicle (0.9% NaCl in sterile water) in their buttock skin.
The injections were each 0.5 ml and spaced 2–4 cm apart. Later, sites
were located reliably, and punch biopsies (4 mm) were obtained
under local anesthesia (lidocaine) at 4 and 12 weeks (n¼ 22) or at 1
and 2 weeks (n¼ 6). Specimens were stored in optimum cutting
temperature at  80 1C, or immediately placed into cell culture
medium for collagen-labeling studies.
Type I procollagen ELISA
Using whole-cell extracts from cryosections (1,000mm), type I
procollagen levels were measured, according to the manufacturer’s
protocol (Takara Bio, Otsu, Japan), as previously described (Orringer
et al., 2011).
Immunohistochemical/immunofluorescence staining
Staining was performed as described previously (Quan et al., 2002b,
2006; Wang et al., 2007; Fisher et al., 2009) using antibodies against
HSP47 (Stressgen Biotechnologies, Victoria, Canada), prolyl-4-
hydroxylase (Acris, Hiddenhausen, Germany), type I procollagen
(Takara Bio; used in human skin studies), type I procollagen
(obtained as described previously (Kang et al., 2005); used in organ
culture studies), Ki67 (BioGenex, San Ramon, CA), and CD31 (BD
Pharmingen, San Diego, CA). Sections were analyzed using Image-
Pro Plus v4.1 (Media Cybernetics, Silver Spring, MD). Matching
subtype, nonimmune antibodies were used as controls to determine
nonspecific signal. In all cases, immune antibodies were used
at concentrations and fixation conditions that yielded no observable
nonspecific staining.
Measurement of gene expression
After total RNA extraction (RNeasy Micro kit, Qiagen, Valencia, CA),
real-time PCR was performed, as described previously (Quan et al.,
2002a, 2004).
Laser capture microdissection
As described previously (Quan et al., 2002a, 2004),B200 fibroblasts
from each cryosection (14mm) were collected in lysis buffer (RNeasy
Micro kit, Qiagen), followed by RNA extraction and reverse
transcriptase–PCR, as described above.
Collagen synthesis in skin organ culture
For each subject, two punch biopsies (2 mm) of vehicle-injected skin
and two punch biopsies (2 mm) of filler-injected skin were cultured in
labeling medium (DMEM/Ham-F12 1:1, v/v, 1% fetal bovine serum,
50mg ml 1 L-ascorbic acid, 2mCi ml 1 [14C]-proline, and 46mg ml 1
L-proline). After incubation at 37 1C under 5% CO2 for 2 days,
samples were rinsed three times in phosphate-buffered saline, frozen
in liquid nitrogen, powdered, and weighed. Soluble proteins were
extracted under rotation for 24 hours at 4 1C in 10 mM Tris, pH 7.5,
0.15 M NaCl, 5 mM EDTA, and protease inhibitors (Complete Mini,
Roche, Indianapolis, IN), followed by centrifugation at 16,000 g at
4 1C for 30 minutes. Mature, extractable collagens were released from
the resulting pellet by adding 1 mg ml 1 pepsin (Sigma-Aldrich, St
Louis, MO) in 0.5 M acetic acid at 4 1C for 16 hours, repeated five
times. The remaining insoluble, cross-linked material was used for
radioactivity counting. Counts per minute were normalized to
milligrams of tissue.
Atomic force microscopy
Cryosections (10mm) were mounted on a microscope cover glass
(1.2 mm diameter, Fisher Scientific, Pittsburgh, PA), allowed to air-dry
for at least 24 hours, and examined using a Dimension Icon AFM
system (Bruker AXS, Santa Barbara, CA) in tapping mode, with a
silicon-etched cantilever (NSC15/AIBS, MikroMasch, San Jose, CA)
with a full tip cone angle of B401 and a tip radius of curvature
B10 nm. Images were acquired at a scan rate of 1.0 Hz at 512 512
pixel resolution, with integral and proportional gain settings of 0.4
and 0.6, respectively. Image quality was optimized by dynamically
lowering the scan rate and set point and by increasing the gains and
drive amplitude. Images were analyzed using NanoScope Analysis
software v1.20 (Bruker AXS).
Dermal equivalent cultures
Collagen lattices were prepared using early passage (o10 passages)
primary adult dermal fibroblasts (2 105), obtained as
previously described (Fisher et al., 1991), mixed with type I
collagen from calf skin (6 mg ml 1, Elastin Products, Owensville,
MO) and medium (pH 7.2, DMEM, 44 mM NaHCO3, 4 mM
L-glutamine, 9 mM folic acid, and 1 N NaOH). After the formation of
lattices (0.5 ml per well; Fisher et al., 2009), 10–15ml of filler,
non-cross-linked HA (0.2 mg ml 1, Sigma Chemical, St Louis, MO)
or vehicle (phosphate-buffered saline) was injected into lattice
centers and incubated for 48 hours at 37 1C under 5% CO2. Viable
cells were recovered, as previously described (Fisher et al., 2009).
For certain wells, filler was dispersed/mixed throughout the
medium before lattice formation. For TbRI kinase inhibition,
lattices were pretreated overnight with SB431542 (10mM, Sigma-
Aldrich) or with an equivalent volume of vehicle (DMSO) before filler
injection.
Statistics
Data are presented as means±SEM. When appropriate, logarithmic
transformation of data was performed to achieve normality.
For data with a small sample size (no9), normality was
assumed. Comparisons between treatment groups were assessed
at each time point using the paired t-test. An overall a-level of
0.05 was used to determine statistical significance, and all tests
were two-sided. Data were analyzed using SAS v9.2 (SAS Institute,
Cary, NC).
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